the aid library

LIST OPTIONS

Filter

3978

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Zimbabwe

Africa Center for Disease Control and Prevention (2023) CC

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr... more

Download (4095)

View PDF (987)

Modes of HIV Transmission in Nigeria: Analysis of the Distribution of New HIV Infections in Nigeria and Recommendations for Prevention

National Agency for the Control of AIDS (NACA); UNAIDS; World Bank et al. (2010) C1

External Link

Best Practices for Environmental Cleaning in Healthcare Facilities: in Resource-Limited Settings

Centers for Disease Control and Prevention CDC (2019) C_CDC

Healthcare-associated infections (HAI) are a significant burden globally, with millions of patients affected each year. These infections affect both high- and limited-resource healthcare settings, but in limited-resource settings, rates are approximately twice as high as high-resource settings (15 o... more

Download (1607)

View PDF (2751)

Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations

Bernard M. Branson, S. Michele Owen, Laura G. Wesolowski et Centers for Disease control and Prevention (2014) C_CDC

This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of tests used in combination to improve the accuracy of ... more

Download (1144)

View PDF (870)

Protocolo antirrábico humano

Arbo, A.; F. Ayala; C. Martinez; et al. Progama Nacional de Control de Zoonosis (2013) C1

Download (322)

View PDF (308)

HIV testing in Europe - Evaluation of the impact of the ECDC guidance on HIV testing: increasing uptake and effectiveness in the European Union

European Centre for Disease Prevention and Control (ECDC) European Centre for Disease Prevention and Control (ECDC) (2016) C2

Technical Report

External Link

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Sierra Leone

Africa Center for Disease Control and Prevention (2023) CC

External Link

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Gabon

Africa Center for Disease Control and Prevention (2023) CC

Download (793)

View PDF (2067)

A guide for surveillance of antimicrobial resistance in leprosy: 2017 update
recommended

E. A. Cooreman WHO SEARODepartment of Control of Neglected Tropical Diseases (2017) C_WHO

In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf... more

External Link

Sexually Transmitted Diseases Treatment Guidelines, 2015

Centers for Disease Control and Prevention (2015) CC

Download (835)

View PDF (1304)

Global AIDS Response: Country Progress Report Nigeria 2015

National Agency for the Control of AIDS (NACA); UNAIDS; Federal Ministry of Health, Nigeria (2015) C1

Download (247)

View PDF (267)

Contact tracing: Public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union -third update

European Centers for Disease Control and Prevention ECDC (2020) C_CDC

This document aims to help EU/EEA public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 cases. It outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-... more

Download (293)

View PDF (795)

Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis

Centers for Disease Control and Prevention (2013) C_CDC

MMWR: Recommendations and Reports / Vol. 62 / No. 9 Morbidity and Mortality Weekly Report October 25, 2013

Download (250)

View PDF (378)

Redefining the Antibiotic Stewardship Team

Centers for Disease Control and Prevention CDC, American Nurses Association ANA (2017) C_CDC

Recommendations from the American Nurses Association/Centers for Disease Control and Prevention Workgroup on the Role of Registered Nurses in Hospital Antibiotic Stewardship Practices

External Link

A national survey of public awareness of antimicrobial resistance in Nigeria

Chukwu, E., Oladele, D., Awoderu, O. et al. Antimicrobial Resistance & Infection Control (2020) CC

Background: One of the objectives of the Global Action Plan by the World Health Organization (WHO) to contain antimicrobial resistance (AMR), is to improve global awareness through effective communication and education. Comprehensive information on the level of awareness of AMR among Nigerian public... more

Download (206)

View PDF (291)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (763)

View PDF (860)

India: Nutrition Guidelines for HIV-Exposed and Infected Children (0-14 Years of Age)

Department of Aids Control, NACO, Ministry of Health and Family Welfare, Government of India (2013) C1

Download (238)

View PDF (420)

Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV

European Centre for Disease Prevention and Control ECDC (2020) C1

This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ... more